MusthInsider

Latest On Mirum Pharmaceuticals, Inc (MIRM):

Updated on: March 18, 2021

Date/Time	Type	Description	Signal
2023-05-07 08:03 EST	News	Mirum Pharmaceuticals, Inc. (MIRM) Q1 2023 Earnings Call Transcript	N/A
2023-05-05 03:10 EST	News	Mirum Pharmaceuticals Non-GAAP EPS of -$0.80 beats by $0.17, revenue of $31.6M beats by $0.81M	N/A
2023-05-04 01:50 EST	News	Mirum Pharmaceuticals Q1 2023 Earnings Preview	N/A
2023-04-30 09:44 EST	News	Mirum Pharmaceuticals: Staying The Course	N/A
2023-04-13 08:06 EST	News	Mirum Pharmaceuticals prices notes worth $275M	N/A
2023-04-12 19:36 EST	News	Mirum Pharmaceuticals reports preliminary unaudited financial results for Q1 2023	N/A
2023-03-09 03:57 EST	News	Mirum Pharmaceuticals, Inc. (MIRM) Q4 2022 Earnings Call Transcript	N/A
2023-02-14 11:04 EST	News	Mirum files for expanded approval of Livmarli in US	N/A
2023-02-01 18:54 EST	News	Mirum Pharmaceuticals: In The Spotlight Following Buyout Of Albireo Pharma	N/A
2022-11-29 09:10 EST	News	Mirum drops plans to develop liver disease candidate in pregnancy	N/A
2022-11-20 19:55 EST	News	Mirum: Potential For European Approval To Move It Forward	N/A
2022-11-10 02:53 EST	News	Mirum Pharmaceuticals, Inc. (MIRM) Q3 2022 Earnings Call Transcript	N/A
2022-11-09 08:41 EST	News	Mirum Pharmaceuticals GAAP EPS of -$1.02 beats by $0.05, revenue of $18.78M misses by $2.03M	N/A
2022-10-25 00:08 EST	News	Mirum says liver disease therapy met main goal in late-stage study	N/A
2022-10-14 19:50 EST	News	Mirum's liver disease drug Livmarli gets EMA committee nod for approval in EU	N/A
2022-08-17 21:12 EST	News	Mirum: Great Sales Start For Livmarli Paves The Way For Long-Term Growth	N/A
2022-08-10 20:11 EST	News	Mirum Pharmaceuticals stock falls prices $80.0M stock offering	N/A
2022-08-10 02:57 EST	News	Mirum Pharmaceuticals falls aftermarket on $80M stock offering	N/A
2022-08-08 04:34 EST	News	Mirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q2 2022 Results - Earnings Call Transcript	N/A
2022-08-05 05:13 EST	News	Mirum Pharmaceuticals GAAP EPS of -$0.84 beats by $0.31, revenue of $17.5M beats by $2.08M	N/A
2022-08-03 23:16 EST	News	Mirum Pharmaceuticals Q2 2022 Earnings Preview	N/A
2022-05-27 23:11 EST	News	Mirum Pharmaceuticals: Post-Approval Execution Looks Excellent	N/A
2022-05-24 00:37 EST	News	Mirum acquires San Diego-based Satiogen in stock and cash combination	N/A
2022-05-08 01:25 EST	News	Mirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q1 2022 Results - Earnings Call Transcript	N/A
2022-05-07 04:44 EST	News	Mirum Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call Presentation	N/A
2022-05-06 05:07 EST	News	Mirum Pharmaceuticals GAAP EPS of -$1.17 beats by $0.23, revenue of $12.89M beats by $4.43M	N/A
2022-03-10 02:23 EST	News	Mirum Pharmaceuticals reports Q4 results	N/A
2022-03-10 02:23 EST	News	Mirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q4 2021 Results - Earnings Call Transcript	N/A
2022-03-09 09:31 EST	News	Mirum Pharmaceuticals Q4 2021 Earnings Preview	N/A
2022-02-12 01:19 EST	News	Mirum Pharmaceuticals grants stock options under inducement plan	N/A
2021-12-17 06:35 EST	News	Mirum Pharmaceuticals Gets The 'Thumbs Up'	N/A
2021-12-15 14:30 EST	News	Mirum Pharmaceuticals to join NASDAQ Biotechnology Index	N/A
2021-11-17 21:27 EST	News	Mirum Pharmaceuticals to sell Rare Pediatric Disease PRV for $110M	N/A
2021-11-16 04:18 EST	News	Mirum Pharmaceuticals reports Q3 results	N/A
2021-11-16 04:18 EST	News	Mirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q3 2021 Results - Earnings Call Transcript	N/A
2021-11-16 04:18 EST	News	Mirum Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call Presentation	N/A
2021-11-12 04:54 EST	News	Mirum Pharmaceuticals: Livmarli Approval Could Spark A Bull Run For This Young Biotech	N/A
2021-10-27 22:00 EST	News	Warning: MIRM is at high risk of performing badly	N/A
2021-09-29 19:13 EST	News	FDA approves Mirum Pharmaceuticals' Alagille syndrome treatment Livmarli	N/A
2021-09-22 00:37 EST	News	Mirum Pharmaceuticals (MIRM) Investor Presentation - Slideshow	N/A
2021-09-22 00:24 EST	News	Mirum submits application to EMA for maralixibat in Alagille Syndrome	N/A
2021-09-22 00:12 EST	News	Mirum and Takeda ink exclusive licensing agreement to commercialize maralixibat in Japan	N/A
2021-08-25 00:56 EST	News	Mirum And Maralixibat In Pediatric Cholestasis: The Differentiation	N/A
2021-08-08 15:26 EST	News	Mirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q2 2021 Results - Earnings Call Transcript	N/A
2021-08-06 06:42 EST	News	Mirum Pharmaceuticals beats on revenue	N/A
2021-07-27 13:01 EST	News	Mirum Pharma inks maralixibat development deal for rare liver disease in South Korea	N/A
2021-07-21 15:36 EST	News	Mirum Is Undervalued Despite Expected Tough Competition	N/A
2021-07-21 15:35 EST	News	Mirum Pharmaceuticals highlights maralixibat liver disease data analyses	N/A
2021-07-21 15:34 EST	News	Mirum adds veteran biotechnology executive Carol Brosgart to board of directors	N/A
2021-07-21 15:27 EST	News	Analysis shows safety of Mirum's maralixibat for liver disorder maintained over five years	N/A

About Mirum Pharmaceuticals, Inc (MIRM):

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's lead product candidate is Maralixibat, an investigational oral drug that is in Phase 3 clinical trial for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It is also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. The company was incorporated in 2018 and is headquartered in Foster City, California.

See Advanced Chart

General

Name Mirum Pharmaceuticals, Inc
Symbol MIRM
Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
SectorHealthcare
IndustryBiotechnology
Full Time Employees 68
Fiscal Year EndDecember
IPO Date2019-07-18
Gic SectorHealth Care
Gic GroupPharmaceuticals, Biotechnology & Life Sciences
Gic IndustryBiotechnology
Web URLhttp://www.mirumpharma.com

Valuation

Price/Book (Most Recent Quarter) 4.53

Financials

Most Recent Quarter 2020-12-31
Current Year EPS Estimate -$3.56
Next Year EPS Estimate -$2.39
Next Quarter EPS Estimate -$0.64
Return on Assets -34%
Return on Equity -68%
Earnings Per Share -$28.94
Revenue Per Share $0
Quarterly Earnings Growth 0%

Highlights

Market Capitalization 610.52 million
PE Ratio -18.84
Analyst Target Price $50.29
Book Value Per Share $6.48

Share Statistics

Shares Outstanding 30.42 million
Shares Float 12.19 million
% Held by Insiders 909%
% Held by Institutions 70.89%
Shares Short 674051
Shares Short Prior Month 637658
Short Ratio 5.61
Short % of Float 4%
Short % of Shares Outstanding 2%

Technicals

52 Week High $27.43
52 Week Low $10.14
50 Day Moving Average 19.23
200 Day Moving Average 19.6

Dividends

Dividend Date N/A
ExDividend Date N/A
Dividend Yield 0%

Mirum Pharmaceuticals, Inc (MIRM) Dividend Calendar:

Ex-Dividend Date	Payment Date	Record Date	Declared Date	Amount

Mirum Pharmaceuticals, Inc (MIRM) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

Quarter Date	Report Date	Actual Revenue	Reported EPS	EPS Estimate	Deviation from Estimate
2020-12-31	2021-03-09	$N/A	-$1.43	-$0.98	-45.49%
2020-09-30	2020-11-12	$N/A	-$0.86	-$0.98	12.46%
2020-06-30	2020-08-06	$N/A	-$0.93	-$0.87	-6.5%
2020-03-31	2020-05-07	$N/A	-$0.86	-$0.84	-2.83%
2019-12-31	2020-03-12	$N/A	-$0.79	-$0.85	6.73%
2019-09-30	2019-11-06	$N/A	-$0.84	-$0.63	-34.14%
2019-06-30	2019-08-28	$N/A	-$0.59	-$0.59	0.47%

Mirum Pharmaceuticals, Inc (MIRM) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:

Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares

Cash Flow:

Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures

Balance Sheet:

Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Mirum Pharmaceuticals, Inc (MIRM) Chart:

Mirum Pharmaceuticals, Inc (MIRM) News:

Below you will find a list of latest news for Mirum Pharmaceuticals, Inc (MIRM) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Mirum Pharmaceuticals, Inc (MIRM) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date:

Options Type:

Moneyness:

Expiration Date	Strike	Last Price	Type	Volume	Open Interest	Implied Volatility	In The Money	Change	Change Percent
2025-09-19	30	0	CALL	0	0	272.83	TRUE	0	0
2025-09-19	35	0	CALL	0	0	230.27	TRUE	0	0
2025-09-19	40	0	CALL	0	0	190.77	TRUE	0	0
2025-09-19	45	0	CALL	0	0	158.82	TRUE	0	0
2025-09-19	50	0	CALL	0	0	61.59	TRUE	0	0
2025-09-19	55	6.05	CALL	0	4	44.67	TRUE	0	0
2025-09-19	60	3.55	CALL	0	69	75.66	TRUE	0	0
2025-09-19	65	4.52	CALL	3	140	19.89	TRUE	0.72	0.19
2025-09-19	70	1.94	CALL	9	98	29.13	FALSE	0.14	0.08
2025-09-19	75	0.65	CALL	2	1	31.47	FALSE	0.65	0
2025-09-19	80	0	CALL	0	0	77.06	FALSE	0	0
2025-09-19	30	0	PUT	0	0	277.02	FALSE	0	0
2025-09-19	35	0	PUT	0	0	234.47	FALSE	0	0
2025-09-19	40	0	PUT	0	0	197.89	FALSE	0	0
2025-09-19	45	1.25	PUT	0	27	165.51	FALSE	0	0
2025-09-19	50	0	PUT	0	0	66.02	FALSE	0	0
2025-09-19	55	0.32	PUT	0	4	108.84	FALSE	0	0
2025-09-19	60	0	PUT	0	0	82.69	FALSE	0	0
2025-09-19	65	2.36	PUT	0	2	40.85	FALSE	0	0
2025-09-19	70	0	PUT	0	0	34.8	TRUE	0	0
2025-09-19	75	0	PUT	0	0	39.45	TRUE	0	0
2025-09-19	80	0	PUT	0	0	46.14	TRUE	0	0
2025-10-17	20	0	CALL	0	0	275.71	TRUE	0	0
2025-10-17	22.5	0	CALL	0	0	250.86	TRUE	0	0
2025-10-17	25	0	CALL	0	0	225.88	TRUE	0	0
2025-10-17	30	0	CALL	0	0	189.6	TRUE	0	0
2025-10-17	35	19	CALL	0	11	74.26	TRUE	0	0
2025-10-17	40	0	CALL	0	0	52.01	TRUE	0	0
2025-10-17	45	4.5	CALL	0	12	110.96	TRUE	0	0
2025-10-17	50	10.7	CALL	0	0	93.73	TRUE	0	0
2025-10-17	55	3.71	CALL	0	14	77.14	TRUE	0	0
2025-10-17	60	7.7	CALL	0	84	34.55	TRUE	0	0
2025-10-17	65	0	CALL	0	2	34.79	TRUE	0	0
2025-10-17	70	2	CALL	0	2	32.27	FALSE	0	0
2025-10-17	75	0	CALL	0	2	41.32	FALSE	0	0
2025-10-17	80	0	CALL	0	0	54.3	FALSE	0	0
2025-10-17	20	0	PUT	0	0	165.05	FALSE	0	0
2025-10-17	22.5	0	PUT	0	0	256.47	FALSE	0	0
2025-10-17	25	0	PUT	0	0	234.83	FALSE	0	0
2025-10-17	30	0	PUT	0	1	198.23	FALSE	0	0
2025-10-17	35	0	PUT	0	0	167.88	FALSE	0	0
2025-10-17	40	0	PUT	0	1	141.78	FALSE	0	0
2025-10-17	45	0	PUT	0	8	118.69	FALSE	0	0
2025-10-17	50	7.6	PUT	0	6	97.76	FALSE	0	0
2025-10-17	55	0	PUT	0	0	78.3	FALSE	0	0
2025-10-17	60	3.7	PUT	0	0	59.69	FALSE	0	0
2025-10-17	65	0	PUT	0	0	41.05	FALSE	0	0
2025-10-17	70	0	PUT	0	0	34.83	TRUE	0	0
2025-10-17	75	0	PUT	0	0	33.05	TRUE	0	0
2025-10-17	80	0	PUT	0	0	40.23	TRUE	0	0
2025-12-19	15	0	CALL	0	0	231.52	TRUE	0	0
2025-12-19	17.5	0	CALL	0	0	207.37	TRUE	0	0
2025-12-19	20	0	CALL	0	0	181.72	TRUE	0	0
2025-12-19	22.5	0	CALL	0	0	174.84	TRUE	0	0
2025-12-19	25	0	CALL	0	2	154.85	TRUE	0	0
2025-12-19	30	0	CALL	0	0	127.34	TRUE	0	0
2025-12-19	35	0	CALL	0	4	110.01	TRUE	0	0
2025-12-19	40	12	CALL	0	44	48.94	TRUE	0	0
2025-12-19	45	9.5	CALL	0	2	26.25	TRUE	0	0
2025-12-19	50	20.3	CALL	1	49	42.41	TRUE	20.3	0
2025-12-19	55	4.45	CALL	0	4	36.91	TRUE	0	0
2025-12-19	60	7.6	CALL	0	26	36.61	TRUE	0	0
2025-12-19	65	8.09	CALL	0	188	35.54	TRUE	0	0
2025-12-19	70	0	CALL	0	0	36	FALSE	0	0
2025-12-19	75	2.5	CALL	0	8	36.29	FALSE	0	0
2025-12-19	80	0	CALL	0	0	36.47	FALSE	0	0
2025-12-19	85	0	CALL	0	0	44.12	FALSE	0	0
2025-12-19	90	0	CALL	0	0	50.84	FALSE	0	0
2025-12-19	15	0	PUT	0	0	134.58	FALSE	0	0
2025-12-19	17.5	0	PUT	0	0	214.71	FALSE	0	0
2025-12-19	20	0	PUT	0	1	122.88	FALSE	0	0
2025-12-19	22.5	0.1	PUT	0	4	104.16	FALSE	0	0
2025-12-19	25	0	PUT	0	1	162.77	FALSE	0	0
2025-12-19	30	0	PUT	0	2	137.52	FALSE	0	0
2025-12-19	35	0	PUT	0	2	116.59	FALSE	0	0
2025-12-19	40	1.65	PUT	0	989	98.6	FALSE	0	0
2025-12-19	45	0	PUT	0	9	82.69	FALSE	0	0
2025-12-19	50	5.4	PUT	0	6	68.28	FALSE	0	0
2025-12-19	55	5.1	PUT	0	2	54.89	FALSE	0	0
2025-12-19	60	0	PUT	0	0	42.95	FALSE	0	0
2025-12-19	65	0	PUT	0	0	38.55	FALSE	0	0
2025-12-19	70	0	PUT	0	0	38.92	TRUE	0	0
2025-12-19	75	11.2	PUT	0	5	38.67	TRUE	0	0
2025-12-19	80	0	PUT	0	0	37.87	TRUE	0	0
2025-12-19	85	0	PUT	0	0	39.35	TRUE	0	0
2025-12-19	90	0	PUT	0	0	43.91	TRUE	0	0
2026-01-16	22.5	0	CALL	0	0	151.79	TRUE	0	0
2026-01-16	25	35.5	CALL	0	2	138.13	TRUE	0	0
2026-01-16	30	0	CALL	0	0	115.08	TRUE	0	0
2026-01-16	35	0	CALL	0	0	50.3	TRUE	0	0
2026-01-16	40	0	CALL	0	0	86.66	TRUE	0	0
2026-01-16	45	0	CALL	0	0	45.04	TRUE	0	0
2026-01-16	50	12.8	CALL	0	36	43.11	TRUE	0	0
2026-01-16	55	11	CALL	0	0	38.41	TRUE	0	0
2026-01-16	60	3.57	CALL	0	20	35.83	TRUE	0	0
2026-01-16	65	8.87	CALL	0	4	37.21	TRUE	0	0
2026-01-16	70	5.6	CALL	0	38	35.55	FALSE	0	0
2026-01-16	75	4.46	CALL	0	127	38	FALSE	0	0
2026-01-16	80	0	CALL	0	0	34.06	FALSE	0	0
2026-01-16	85	0	CALL	0	0	39.37	FALSE	0	0
2026-01-16	90	0	CALL	0	0	45.43	FALSE	0	0
2026-01-16	22.5	0	PUT	0	0	160.4	FALSE	0	0
2026-01-16	25	0	PUT	0	0	146.94	FALSE	0	0
2026-01-16	30	0	PUT	0	0	124.2	FALSE	0	0
2026-01-16	35	1.3	PUT	0	1	105.35	FALSE	0	0
2026-01-16	40	0	PUT	0	0	89.15	FALSE	0	0
2026-01-16	45	5	PUT	0	2	74.83	FALSE	0	0
2026-01-16	50	0	PUT	0	0	61.85	FALSE	0	0
2026-01-16	55	3.5	PUT	0	10	49.81	FALSE	0	0
2026-01-16	60	3.8	PUT	0	2	39.07	FALSE	0	0
2026-01-16	65	0	PUT	0	0	38	FALSE	0	0
2026-01-16	70	0	PUT	0	0	38.5	TRUE	0	0
2026-01-16	75	0	PUT	0	0	38.45	TRUE	0	0
2026-01-16	80	0	PUT	0	0	38.58	TRUE	0	0
2026-01-16	85	0	PUT	0	0	38.45	TRUE	0	0
2026-01-16	90	0	PUT	0	0	40.21	TRUE	0	0
2026-04-17	35	0	CALL	0	0	46.32	TRUE	0	0
2026-04-17	40	0	CALL	0	0	45.24	TRUE	0	0
2026-04-17	45	0	CALL	0	0	44.86	TRUE	0	0
2026-04-17	50	0	CALL	0	0	40.3	TRUE	0	0
2026-04-17	55	0	CALL	0	0	41.53	TRUE	0	0
2026-04-17	60	0	CALL	0	0	40.36	TRUE	0	0
2026-04-17	65	11.07	CALL	0	80	37.73	TRUE	0	0
2026-04-17	70	0	CALL	0	0	37.3	FALSE	0	0
2026-04-17	75	0	CALL	0	0	37.56	FALSE	0	0
2026-04-17	80	5.25	CALL	0	128	37.81	FALSE	0	0
2026-04-17	85	0	CALL	0	0	36.38	FALSE	0	0
2026-04-17	90	0	CALL	0	0	36.95	FALSE	0	0
2026-04-17	95	0	CALL	0	0	39.29	FALSE	0	0
2026-04-17	100	0	CALL	0	0	43.21	FALSE	0	0
2026-04-17	35	0	PUT	0	0	83.72	FALSE	0	0
2026-04-17	40	0	PUT	0	0	70.97	FALSE	0	0
2026-04-17	45	0	PUT	0	0	59.7	FALSE	0	0
2026-04-17	50	0	PUT	0	0	49.1	FALSE	0	0
2026-04-17	55	0	PUT	0	0	40.73	FALSE	0	0
2026-04-17	60	5.2	PUT	0	1	40.7	FALSE	0	0
2026-04-17	65	0	PUT	0	0	40.31	FALSE	0	0
2026-04-17	70	0	PUT	0	0	38.17	TRUE	0	0
2026-04-17	75	0	PUT	0	0	38.37	TRUE	0	0
2026-04-17	80	0	PUT	0	0	39.18	TRUE	0	0
2026-04-17	85	0	PUT	0	0	40.54	TRUE	0	0
2026-04-17	90	0	PUT	0	0	40.8	TRUE	0	0
2026-04-17	95	0	PUT	0	0	39.97	TRUE	0	0
2026-04-17	100	0	PUT	0	0	42.55	TRUE	0	0

Latest MIRM Trades:

Date	Shares	Price
Jun 13, 2022 7:59 PM EST	4	$20.27
Jun 13, 2022 7:59 PM EST	34	$20.26
Jun 13, 2022 7:59 PM EST	50	$20.26
Jun 13, 2022 7:59 PM EST	50	$20.26
Jun 13, 2022 7:59 PM EST	100	$20.24

Mirum Pharmaceuticals, Inc (MIRM) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Form Type:

Date	Form Type	Form Name	Link
2020-06-16	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1759425/000156459020029555/0001564590-20-029555-index.htm
2019-06-28	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1759425/000000000019010501/0000000000-19-010501-index.htm
2019-07-10	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1759425/000000000019010921/0000000000-19-010921-index.htm
2019-12-30	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1759425/000000000019016859/0000000000-19-016859-index.htm
2020-08-07	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1759425/000000000020007237/0000000000-20-007237-index.htm
2019-12-27	DRS	Draft Registration Statement	https://www.sec.gov/Archives/edgar/data/1759425/000095012319012069/0000950123-19-012069-index.htm
2019-07-30	SC 13D	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1759425/000107261319000249/0001072613-19-000249-index.htm
2019-12-16	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1759425/000117266119002410/0001172661-19-002410-index.htm
2020-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1759425/000117266120000737/0001172661-20-000737-index.htm
2019-06-27	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1759425/000119312519184371/0001193125-19-184371-index.htm
2019-07-08	S-1/A	General form for registration of securities under the Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1759425/000119312519189959/0001193125-19-189959-index.htm
2019-07-08	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1759425/000119312519189965/0001193125-19-189965-index.htm
2019-07-12	S-1/A	General form for registration of securities under the Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1759425/000119312519193277/0001193125-19-193277-index.htm
2019-07-12	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1759425/000119312519193289/0001193125-19-193289-index.htm
2019-07-15	8-A12B	Registration of securities [Section 12(b)]	https://www.sec.gov/Archives/edgar/data/1759425/000119312519194022/0001193125-19-194022-index.htm
2019-07-15	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1759425/000119312519194112/0001193125-19-194112-index.htm
2019-07-15	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1759425/000119312519194115/0001193125-19-194115-index.htm
2019-07-18	424B4	Prospectus [Rule 424(b)(4)]	https://www.sec.gov/Archives/edgar/data/1759425/000119312519196500/0001193125-19-196500-index.htm
2019-07-23	SC 13D	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1759425/000119312519200063/0001193125-19-200063-index.htm
2019-07-25	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1759425/000119312519202499/0001193125-19-202499-index.htm
2019-07-26	SC 13D	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1759425/000119312519204056/0001193125-19-204056-index.htm
2019-08-01	SC 13D	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1759425/000119312519210092/0001193125-19-210092-index.htm
2019-08-28	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1759425/000119312519232419/0001193125-19-232419-index.htm
2019-08-28	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1759425/000119312519232544/0001193125-19-232544-index.htm
2019-12-27	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1759425/000119312519324949/0001193125-19-324949-index.htm
2020-01-06	S-1	General form for registration of securities under the Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1759425/000119312520002291/0001193125-20-002291-index.htm
2020-01-06	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1759425/000119312520002347/0001193125-20-002347-index.htm
2020-01-06	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1759425/000119312520002352/0001193125-20-002352-index.htm
2020-01-09	424B4	Prospectus [Rule 424(b)(4)]	https://www.sec.gov/Archives/edgar/data/1759425/000119312520004784/0001193125-20-004784-index.htm
2020-01-14	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1759425/000119312520007165/0001193125-20-007165-index.htm
2020-01-17	SC 13D/A	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1759425/000119312520009903/0001193125-20-009903-index.htm
2020-04-29	SC 13D/A	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1759425/000119312520126318/0001193125-20-126318-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000119380519000651/0001193805-19-000651-index.htm
2019-07-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000119380519000660/0001193805-19-000660-index.htm
2019-07-24	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1759425/000119380519000662/0001193805-19-000662-index.htm
2020-02-13	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1759425/000119380520000192/0001193805-20-000192-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042429/0001209191-19-042429-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042433/0001209191-19-042433-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042435/0001209191-19-042435-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042437/0001209191-19-042437-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042439/0001209191-19-042439-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042441/0001209191-19-042441-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042442/0001209191-19-042442-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042445/0001209191-19-042445-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042446/0001209191-19-042446-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042447/0001209191-19-042447-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042448/0001209191-19-042448-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042449/0001209191-19-042449-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042451/0001209191-19-042451-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042453/0001209191-19-042453-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042454/0001209191-19-042454-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042455/0001209191-19-042455-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042456/0001209191-19-042456-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042457/0001209191-19-042457-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042458/0001209191-19-042458-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042460/0001209191-19-042460-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042470/0001209191-19-042470-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042476/0001209191-19-042476-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042479/0001209191-19-042479-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042482/0001209191-19-042482-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042486/0001209191-19-042486-index.htm
2019-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042489/0001209191-19-042489-index.htm
2019-07-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042657/0001209191-19-042657-index.htm
2019-07-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042970/0001209191-19-042970-index.htm
2019-07-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043021/0001209191-19-043021-index.htm
2019-07-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043022/0001209191-19-043022-index.htm
2019-07-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043023/0001209191-19-043023-index.htm
2019-07-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043024/0001209191-19-043024-index.htm
2019-07-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043052/0001209191-19-043052-index.htm
2019-07-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043053/0001209191-19-043053-index.htm
2019-07-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043054/0001209191-19-043054-index.htm
2019-07-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043055/0001209191-19-043055-index.htm
2019-07-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043056/0001209191-19-043056-index.htm
2019-07-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043057/0001209191-19-043057-index.htm
2019-07-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043058/0001209191-19-043058-index.htm
2019-07-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043059/0001209191-19-043059-index.htm
2019-07-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043060/0001209191-19-043060-index.htm
2019-07-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043061/0001209191-19-043061-index.htm
2019-07-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043062/0001209191-19-043062-index.htm
2019-07-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043063/0001209191-19-043063-index.htm
2019-09-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm
2019-09-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119049090/0001209191-19-049090-index.htm
2019-09-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119049091/0001209191-19-049091-index.htm
2019-09-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119049092/0001209191-19-049092-index.htm
2019-09-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119049309/0001209191-19-049309-index.htm
2019-09-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119050105/0001209191-19-050105-index.htm
2019-10-28	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119054233/0001209191-19-054233-index.htm
2019-10-28	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919119054240/0001209191-19-054240-index.htm
2020-01-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919120000307/0001209191-20-000307-index.htm
2020-01-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919120003335/0001209191-20-003335-index.htm
2020-01-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919120003338/0001209191-20-003338-index.htm
2020-01-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919120003342/0001209191-20-003342-index.htm
2020-01-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919120003345/0001209191-20-003345-index.htm
2020-01-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919120003348/0001209191-20-003348-index.htm
2020-03-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919120020665/0001209191-20-020665-index.htm
2020-04-30	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919120026416/0001209191-20-026416-index.htm
2020-04-30	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919120026418/0001209191-20-026418-index.htm
2020-06-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919120036572/0001209191-20-036572-index.htm
2020-06-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919120036581/0001209191-20-036581-index.htm
2020-06-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919120036587/0001209191-20-036587-index.htm
2020-06-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919120036594/0001209191-20-036594-index.htm
2020-06-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919120036597/0001209191-20-036597-index.htm
2020-06-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919120036618/0001209191-20-036618-index.htm
2020-11-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1759425/000120919120056690/0001209191-20-056690-index.htm
2019-07-16	CERT	Certification	https://www.sec.gov/Archives/edgar/data/1759425/000135445719000353/0001354457-19-000353-index.htm
2019-09-10	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1759425/000139506419000029/0001395064-19-000029-index.htm
2019-08-28	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1759425/000156459019033345/0001564590-19-033345-index.htm
2019-11-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1759425/000156459019040998/0001564590-19-040998-index.htm
2019-11-06	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1759425/000156459019041030/0001564590-19-041030-index.htm
2020-03-12	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1759425/000156459020010454/0001564590-20-010454-index.htm
2020-03-12	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1759425/000156459020010471/0001564590-20-010471-index.htm
2020-04-29	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1759425/000156459020019713/0001564590-20-019713-index.htm
2020-04-29	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1759425/000156459020019725/0001564590-20-019725-index.htm
2020-05-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1759425/000156459020022831/0001564590-20-022831-index.htm
2020-05-07	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1759425/000156459020022856/0001564590-20-022856-index.htm
2020-05-07	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1759425/000156459020023010/0001564590-20-023010-index.htm
2020-06-16	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1759425/000156459020029555/0001564590-20-029555-index.htm
2020-08-03	S-3	Registration statement under Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1759425/000156459020035305/0001564590-20-035305-index.htm
2020-08-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1759425/000156459020037717/0001564590-20-037717-index.htm
2020-08-06	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1759425/000156459020037771/0001564590-20-037771-index.htm
2020-08-10	S-3/A	Registration statement under Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1759425/000156459020038927/0001564590-20-038927-index.htm
2019-07-17	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1759425/999999999519001627/9999999995-19-001627-index.htm
2020-01-08	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1759425/999999999520000041/9999999995-20-000041-index.htm
2020-08-12	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1759425/999999999520002122/9999999995-20-002122-index.htm
2019-07-10	SEC STAFF	SEC Staff Letter: REDACTED EXHIBIT	https://www.sec.gov/Archives/edgar/data/1759425/999999999719006082/9999999997-19-006082-index.htm

Mirum Pharmaceuticals, Inc (MIRM) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Mirum Pharmaceuticals, Inc (MIRM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 909%
Institutional Ownership: 7089%

Transaction Date	Insider Name	Insider Title	Type	Shares Number	Shares Price	Total Transaction	Shares Held After Transaction	Link
2019-09-10	Laura Brege	Director	Buy	10,000.00	11.22	112,200.00	10,000.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119049309/0001209191-19-049309-index.htm
2019-09-06	Pamela Vig	Chief Scientific Officer	Buy	1,600.00	10.96	17,539.20	1,600.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119049091/0001209191-19-049091-index.htm
2019-09-06	Pamela Vig	Chief Scientific Officer	Buy	12.00	11.88	142.56	1,612.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119049091/0001209191-19-049091-index.htm
2019-07-22	James E Flynn	10% Share Holder	Buy	166,000.00	15.00	2,490,000.00	166,000.00	https://www.sec.gov/Archives/edgar/data/1759425/000119380519000660/0001193805-19-000660-index.htm
2019-09-06	Laurent Fischer	Director	Buy	1,720.00	10.71	18,429.28	1,720.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm
2019-07-22	James E Flynn	10% Share Holder	Buy	166,000.00	15.00	2,490,000.00	1,724,456.00	https://www.sec.gov/Archives/edgar/data/1759425/000119380519000660/0001193805-19-000660-index.htm
2019-09-06	Ian Clements	SVP Finance & Communications	Buy	1,801.00	11.07	19,937.07	1,801.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119049092/0001209191-19-049092-index.htm
2019-07-22	Niall O'Donnell	Director	Buy	300,000.00	15.00	4,500,000.00	1,921,118.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043023/0001209191-19-043023-index.htm
2019-09-06	Christopher Peetz	President and CEO	Buy	4,750.00	10.91	51,805.88	192,250.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119049090/0001209191-19-049090-index.htm
2019-09-09	Christopher Peetz	President and CEO	Buy	2,000.00	10.90	21,800.00	194,250.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119049090/0001209191-19-049090-index.htm
2019-09-09	Christopher Peetz	President and CEO	Buy	2,320.00	11.35	26,332.00	196,570.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119049090/0001209191-19-049090-index.htm
2019-07-22	Holdings A/S Novo	10% Share Holder	Buy	575,000.00	15.00	8,625,000.00	2,445,147.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119042970/0001209191-19-042970-index.htm
2020-10-30	Edwin Jonathan Tucker	Chief Medical Officer	Buy	25,000.00	7.70	192,500.00	31,000.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919120056690/0001209191-20-056690-index.htm
2019-09-09	Laurent Fischer	Director	Buy	1,670.00	10.54	17,601.80	3,390.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm
2020-03-19	Edwin Jonathan Tucker	Chief Medical Officer	Buy	2,000.00	9.91	19,818.00	3,500.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919120020665/0001209191-20-020665-index.htm
2019-07-22	Frazier Life Sciences IX, L.P.	10% Share Holder	Buy	450,000.00	15.00	6,750,000.00	3,566,912.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043024/0001209191-19-043024-index.htm
2019-07-22	Patrick J Heron	Director	Buy	450,000.00	15.00	6,750,000.00	3,566,912.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043022/0001209191-19-043022-index.htm
2019-09-09	Laurent Fischer	Director	Buy	300.00	11.30	3,390.00	3,690.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm
2019-09-06	Ian Clements	SVP Finance & Communications	Buy	2,199.00	11.87	26,102.13	4,000.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119049092/0001209191-19-049092-index.htm
2019-07-22	Ali Behbahani	10% Share Holder	Buy	450,000.00	15.00	6,750,000.00	4,186,243.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043055/0001209191-19-043055-index.htm
2019-07-22	Anthony A. Jr. Florence	10% Share Holder	Buy	450,000.00	15.00	6,750,000.00	4,186,243.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043057/0001209191-19-043057-index.htm
2019-07-22	Carmen Chang	10% Share Holder	Buy	450,000.00	15.00	6,750,000.00	4,186,243.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043056/0001209191-19-043056-index.htm
2019-07-22	DAVID M MOTT	10% Share Holder	Buy	450,000.00	15.00	6,750,000.00	4,186,243.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043060/0001209191-19-043060-index.htm
2019-07-22	FOREST BASKETT	10% Share Holder	Buy	450,000.00	15.00	6,750,000.00	4,186,243.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043054/0001209191-19-043054-index.htm
2019-07-22	JOSHUA MAKOWER	10% Share Holder	Buy	450,000.00	15.00	6,750,000.00	4,186,243.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043059/0001209191-19-043059-index.htm
2019-07-22	Mohamad Makhzoumi	10% Share Holder	Buy	450,000.00	15.00	6,750,000.00	4,186,243.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043058/0001209191-19-043058-index.htm
2019-07-22	New Enterprise Associates 16, L.P.	10% Share Holder	Buy	450,000.00	15.00	6,750,000.00	4,186,243.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043052/0001209191-19-043052-index.htm
2019-07-22	Paul Edward Walker	10% Share Holder	Buy	450,000.00	15.00	6,750,000.00	4,186,243.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043063/0001209191-19-043063-index.htm
2019-07-22	PETER J BARRIS	10% Share Holder	Buy	450,000.00	15.00	6,750,000.00	4,186,243.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043053/0001209191-19-043053-index.htm
2019-07-22	Peter W. Sonsini	10% Share Holder	Buy	450,000.00	15.00	6,750,000.00	4,186,243.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043062/0001209191-19-043062-index.htm
2019-07-22	SCOTT D SANDELL	10% Share Holder	Buy	450,000.00	15.00	6,750,000.00	4,186,243.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119043061/0001209191-19-043061-index.htm
2019-09-10	Laurent Fischer	Director	Buy	960.00	10.29	9,881.47	4,650.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm
2019-09-16	Laurent Fischer	Director	Buy	452.00	9.47	4,280.44	5,102.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119050105/0001209191-19-050105-index.htm
2020-03-20	Edwin Jonathan Tucker	Chief Medical Officer	Buy	2,500.00	11.90	29,740.00	6,000.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919120020665/0001209191-20-020665-index.htm
2019-09-17	Laurent Fischer	Director	Buy	1,648.00	9.37	15,435.17	6,750.00	https://www.sec.gov/Archives/edgar/data/1759425/000120919119050105/0001209191-19-050105-index.htm

Mirum Pharmaceuticals, Inc

(NASDAQ:MIRM)